Neuren Pharmaceuticals LimitedASX: NEU

DAYBUE Q1 net sales US$75.9m, full-year guidance US$370-420m

May 9, 2024 at 4:30 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment